That the Parliament recognises the scale of the mental health emergency in Scotland; notes with concern the lack of adequate provision for neurodevelopmental conditions, particularly in the context of a sharp rise in demand for neurodiversity assessments and treatment for adults and children following the COVID-19 pandemic; further notes the additional pressure on services caused by the global shortage of attention deficit hyperactivity disorder (ADHD) medication, which has led to the closure of titration clinics in some areas and significantly impacted waiting times and access to care; recognises the profound distress and disruption this causes for individuals and families who are left without timely diagnosis or support; acknowledges the knock-on effects on child and adolescent mental health services (CAMHS), as well as the wider economic consequences of rising levels of economic inactivity linked to unmet mental health needs; notes the pressure that this puts on GPs and primary care; further notes with concern the widespread removal of shared care arrangements where patients who obtained a private diagnosis could receive ongoing care and medication through the Scottish NHS; expresses disappointment at the Scottish Government’s failure to meet its commitment to allocate 10% of NHS spending to mental health and 1% to CAMHS; calls on the Scottish Government to work urgently with NHS boards and local authorities to devise a robust protocol on the use of shared care arrangements to allow for their use where appropriate, and further calls on the Scottish Government to create neurodevelopmental pathways and stepped care models, as recommended by the National Autism Implementation Team and Royal College of Psychiatrists in the 2021 National Clinical ADHD Pathway Feasibility Study.